T1	Chemical 43 70	Î³-glutamyl-cysteinylglycine
T10	Chemical 816 819	GSH
T11	Chemical 936 947	glutathione
T12	Chemical 1009 1028	reduced glutathione
T13	Chemical 1030 1033	GSH
T14	Chemical 1053 1073	oxidized glutathione
T15	Chemical 1075 1079	GSSG
T16	Chemical 1172 1183	glutathione
T17	Disease 1224 1237	hyperglycemia
#10	AnnotatorNotes T17	DOID:4195
T18	Chemical 1466 1477	glutathione
T19	Disease 1501 1509	diabetic
#12	AnnotatorNotes T19	not found
T2	Chemical 240 251	glutathione
T3	Chemical 253 256	GSH
T4	Disease 302 317	type 2 diabetes
#15	AnnotatorNotes T4	DOID:9352
T5	Chemical 377 388	glutathione
T6	Disease 403 418	type 2 diabetes
T7	Chemical 487 490	GSH
T8	Disease 580 601	uncontrolled diabetes
#19	AnnotatorNotes T8	not found
T9	Chemical 714 717	GSH
T20	Disease 157 173	oxidative stress
#1	AnnotatorNotes T20	D018384
T21	Drug 30 41	Glutathione
#2	AnnotatorNotes T21	D005978
R1	Response Arg1:T21 Arg2:T20	
T22	Biomarker 228 284	erythrocyte glutathione (GSH) concentration is decreased
R2	Association Arg1:T22 Arg2:T4	
T23	Biomarker 377 399	glutathione deficiency
R3	Association Arg1:T23 Arg2:T6	
T24	Biomarker 487 505	GSH synthesis rate
R4	Association Arg1:T24 Arg2:T8	
T25	Biomarker 807 833	reducing GSH concentration
T26	Disease 872 887	type 2 diabetes
T27	Biomarker 918 954	total erythrocyte glutathione levels
T28	Biomarker 992 1048	concentration of reduced glutathione (GSH) was decreased
T29	Biomarker 1053 1099	oxidized glutathione (GSSG) levels were higher
T30	Collection 992 1099	concentration of reduced glutathione (GSH) was decreased and oxidized glutathione (GSSG) levels were higher
R5	Association Arg1:T30 Arg2:T26	
T31	Biomarker 1163 1194	impaired glutathione metabolism
T32	Disease 1301 1317	oxidative stress
T33	Biomarker 1364 1391	microvascular complications
R6	Association Arg1:T33 Arg2:T32	
T34	Biomarker 1452 1488	more impaired glutathione metabolism
R7	Association Arg1:T31 Arg2:T17	
